Genotyping of BCL11A and HBS1L-MYB Single Nucleotide Polymorphisms in β-thalassemia/HbE and Homozygous HbE Subjects with Low and High Levels of HbF
Keywords:β-thalassemia/Hb disease, HbF, homozygous HbE, BCL11A, HBS1L-MYB
Whether multiple single nucleotide polymorphisms (SNPs) of BCL11A and HBS1L-MYB genes affect hemoglobin (Hb)F production and hematological parameter variation in β-thalassemia/HbE and homozygous HbE in Thai subjects with low and high HbF levels are still unclear. Three SNPs of BCL11A gene (rs1427407, rs10189857 and rs11886868) and 3 SNPs of HBS1L-MYB gene (rs4895441, rs9399137 and rs28384513) were analyzed in 45 β-thalassemia/HbE patients who had HbF levels lower and higher than 15 %, and in 50 homozygous HbE who had HbF levels lower and higher than 5 %. Their hematological parameters were measured using automated blood counter. The HbF level was analyzed using high performance liquid chromatography (HPLC). There were no statistical significant differences of allele and genotype frequencies of 3 SNPs in the BCL11A gene between the groups of β-thalassemia/HbE patients and homozygous HbE subjects with low and high HbF levels. Significant differences in the allele frequencies in HBS1L-MYB SNP rs4895441 (p = 0.041) and rs9399137 (p = 0.048) were observed in homozygous HbE subjects with HbF £ 5 % and > 5 %. Moreover, significant differences in MCV (p = 0.005) and trends towards significant differences in MCH (p = 0.057) and HbF levels (p = 0.051) were found in HBS1L-MYB SNP rs9399137 of homozygous HbE subjects. Therefore, the HBS11L-MYB SNPs especially rs9399137 had an effect on HbF production and the variation of hematological parameters in homozygous HbE subjects, but not in β-thalassemia/HbE patients.
MH Steinberg and JG Adams. Hemoglobin A2: Origin, evolution, and aftermath. Blood 1991; 78, 2165-77.
S Fucharoen and P Winichagoon. Thalassemia and abnormal hemoglobin. Int. J. Hematol. 2002; 76, 83-9.
S Fucharoen and P Winichagoon. Hemoglobinopathies in Southeast Asia: Molecular biology and clinical medicine. Hemoglobin 1997; 21, 299-319.
NA Lachant. Hemoglobin E: An emerging hemoglobinopathy in the United States. Am. J. Hematol. 1987; 25, 449-62.
S Fucharoen and P Winichagoon. Clinical and hematologic aspects of hemoglobin E beta-thalassemia. Curr. Opin. Hematol. 2000; 7, 106-12.
G Stamatoyannopoulos. Control of globin gene expression during development and erythroid differentiation. Exp. Hematol. 2005; 33, 259-71.
P Winichagoon, V Thonglairoam, S Fucharoen, P Wilairat, Y Fukumaki and P Wasi. Severity differences in beta-thalassaemia/haemoglobin E syndromes: Implication of genetic factors. Br. J. Haematol. 1993; 83, 633-9.
S Menzel, C Garner, I Gut, F Matsuda, M Yamaguchi, S Heath, M Foglio, D Zelenika, A Boland, H Rooks, S Best, TD Spector, M Farrall, M Lathrop and SL Thein. A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15. Nat. Genet. 2007; 39, 1197-9.
N Pakdee, S Yamsri, G Fucharoen, K Sanchaisuriya, S Pissard and S Fucharoen. Variability of hemoglobin F expression in hemoglobin EE disease: Hematological and molecular analysis. Blood Cells. Mol. Dis. 2014; 53, 11-5.
RA Pandit, S Svasti, O Sripichai, T Munkongdee, K Triwitayakorn, P Winichagoon, S Fucharoen and C Peerapittayamongkol. Association of SNP in exon 1 of HBS1L with hemoglobin F level in beta0-thalassemia/hemoglobin E. Int. J. Hematol. 2008; 88, 357-61.
AE Sedgewick, N Timofeev, P Sebastiani, JC So, ES Ma, LC Chan, G Fucharoen, S Fucharoen, CG Barbosa, BN Vardarajan, LA Farrer, CT Baldwin, MH Steinberg and DH Chui. BCL11A is a major HbF quantitative trait locus in three different populations with beta-hemoglobinopathies. Blood Cells. Mol. Dis. 2008; 41, 255-8.
S Pornprasert, A Moriyama, K Kongthai, J Waneesorn, K Jaiping, K Treesuwan and Y Hattori. Detection of beta-thalassemia/hemoglobin E disease in samples which initially were diagnosed as homozygous hemoglobin E. Clin. Lab. 2013; 59, 693-7.
A Premawardhena, CA Fisher, NF Olivieri, S de Silva, M Arambepola, W Perera, A O'Donnell, TE Peto, V Viprakasit, L Merson, G Muraca and DJ Weatherall. Haemoglobin E beta thalassaemia in Sri Lanka. Lancet 2005; 366, 1467-70.
S Ekwattanakit, Y Monteerarat, S Riolueang, K Tachavanich and V Viprakasit. Association of xmn I polymorphism and hemoglobin E haplotypes on postnatal gamma globin gene expression in homozygous hemoglobin E. Adv. Hematol. 2012; 2012, 528075.
TK Nguyen, P Joly, C Bardel, M Moulsma, N Bonello-Palot and A Francina. The XmnI (G)gamma polymorphism influences hemoglobin F synthesis contrary to BCL11A and HBS1L-MYB SNPs in a cohort of 57 beta-thalassemia intermedia patients. Blood Cells. Mol. Dis. 2010; 45, 124-7.
W Prasing, T Odawara, P Traisathit, Y Yamashiro, Y Hattori and S Pornprasert. Analysis of the Xmn1-(G) gamma polymorphism in beta-thalassemia/hemoglobin E (HbE) and homozygous HbE patients with low and high levels of HbF. Int. J. Lab. Hematol. 2015; 37, e25-e28.
S Pornprasert, C Kasemrad and K Sukunthamala. Diagnosis of thalassemia on dried blood spot samples by high performance liquid chromatography. Hemoglobin 2010; 34, 486-94.
S Pornprasert, A Phusua, S Suanta, R Saetung and T Sanguansermsri. Detection of alpha-thalassemia-1 Southeast Asian type using real-time gap-PCR with SYBR Green1 and high resolution melting analysis. Eur. J. Haematol. 2008; 80, 510-4.
S Pornprasert, M Punyamung and K Treesuwan. Criteria for detection of alpha-thalassemia-1 Thai type deletion in routine laboratory. Clin. Lab. 2013; 59, 1423-7.
J Old, J Traeger-Synodinos, R Galanello, M Petrou and M Angastiniotis. Prevention of Thalassemias and Other Haemoglobin Disorders. Vol II. Team up Creations Ltd, Nicosia, 2005, p. 85-154.
S Pornprasert and K Sukunthamala. SYTO9 and SYBR GREEN1 with a high-resolution melting analysis for prenatal diagnosis of beta(0)-thalassemia/hemoglobin-E. Eur. J. Haematol. 2010; 85, 424-9.
C Badens, P Joly, I Agouti, I Thuret, K Gonnet, S Fattoum, A Francina , MC Simeoni, A Loundou and Pissard S. Variants in genetic modifiers of beta-thalassemia can help to predict the major or intermedia type of the disease. Haematologica 2011; 96, 1712-4.
SL Thein, S Menzel, M Lathrop and C Garner. Control of fetal hemoglobin: New insights emerging from genomics and clinical implications. Hum. Mol. Genet. 2009; 18, 216-23.
M Nuinoon, W Makarasara, T Mushiroda, I Setianingsih, PA Wahidiyat, O Sripichai, N Kumasaka, A Takahashi, S Svasti, T Munkongdee, S Mahasirimongkol, C Peerapittayamongkol, V Viprakasit, N Kamatani, P Winichagoon, M Kubo, Y Nakamura and S Fucharoen. A genome-wide association identified the common genetic variants influence disease severity in beta0-thalassemia/hemoglobin E. Hum. Genet. 2010; 127, 303-14.
M Uda, R Galanello, S Sanna, G Lettre, VG Sankaran, W Chen, G Usala, F Busonero, A Maschio, G Albai, MG Piras, N Sestu, S Lai, M Dei, A Mulas, L Crisponi, S Naitza, I Asunis, M Deiana, R Nagaraja, L Perseu, S Satta, MD Cipollina, C Sollaino, P Moi, JN Hirschhorn, SH Orkin, GR Abecasis, D Schlessinger and A Cao. Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia. Proc. Natl. Acad. Sci. USA 2008; 105, 1620-5.
S Siriworadechkul, S Jindadamrongwech, S Chuncharunee and S Aupparakkitanon. Implication of globin gene expression, hemoglobin F and hemoglobin E levels on beta-thalassemia/Hb E disease severity. Ann. Clin. Lab. Sci. 2014; 44, 437-42.
W Lemsaddek, I Picanco, F Seuanes, L Mahmal, S Benchekroun, M Khattab, P Nogueira and L Osório-Almeida. Spectrum of beta thalassemia mutations and HbF levels in the heterozygous Moroccan population. Am. J. Hematol. 2003; 73, 161-8.
How to Cite
Copyright (c) 2018 Walailak Journal of Science and Technology (WJST)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.